REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 8th, 2009 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of ____________________ , between HepaLife Technologies, Inc., a Florida corporation (the “ Company ”) and each of the several purchasers signatory hereto (each such purchaser, a “ Subscriber ” and, collectively, the “ Subscribers ”).
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Security Agreement • July 8th, 2009 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus
THIS SERIES C COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________________(the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “ Initial Exercise Date ”) and on or prior to the close of business on the second year anniversary of the Initial Exercise Date (the “ Termination Date ”) but not thereafter, to subscribe for and purchase from HepaLife Technologies, Inc., a Florida corporation (the “ Company ”), up to _____________________ shares (the “ Warrant Shares ”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SUBSCRIPTION AGREEMENT BY AND BETWEEN AND RECITALSSecurities Purchase Agreement • July 8th, 2009 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus • Florida
WHEREAS, the Company is offering on a no minimum basis (the “Offering”) up to an aggregate of 14,117,647 units ( the “Offered Units”) at a price of US $0.425 per Offered Unit or $6,000,000 in the aggregate; each Offered Unit consists of one (1) share (the “ Unit Shares ”) of the Company’s common stock, $0.001 par value per share and one (1) Series C Non-redeemable Warrant (in the form of Exhibit A hereto) to purchase a share of common stock at $ 0.55 per share for a period of 24 months from the date of issuance (the “ Series C Warrants ”);
ContractLoan Agreement • July 8th, 2009 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus • New York
Agreement dated as of May 23, 2008 (the “Agreement”) between HepaLife Technologies, Inc. a Florida corporation with an office at 60 State Street, Suite 700, Boston, MA 02109 (the “Company ”) and Harmel S. Rayat, an individual with an address at 1628 West 1 st Avenue, Suite 216, Vancouver, British Columbia V6J1G1 (the “Lender ”).
